Research Symposium Research Articles

The 2018 St. Luke's University Health Network Annual Research Symposium: Event highlights and scientific abstracts

The 2018 St. Luke's University Health Network Annual Research Symposium: Event highlights and scientific abstracts

VII Scandinavian Copd Research Symposium, Holmenkollen, Oslo 18th–19th November 2016

The overall aim of this thesis was to assess measurement properties of methods suitable for screening or monitoring of physical capacity and physical activity in subjects with chronic obstructive p ...

The fourth annual BRDS on genome editing and silencing for precision medicines.

Precision medicine is promising for treating human diseases, as it focuses on tailoring drugs to a patient's genes, environment, and lifestyle. The need for personalized medicines has opened the doors for turning nucleic acids into therapeutics. Although gene therapy has the potential to treat and cure genetic and acquired diseases, it needs to overcome certain obstacles before creating the overall prescription drugs. Recent advancement in the life science has helped to understand the effective manipulation and delivery of genome-engineering tools better. The use of sequence-specific nucleases allows genetic changes in human cells to be easily made with higher efficiency and precision than before. Nanotechnology has made rapid advancement in the field of drug delivery, but the delivery of nucleic acids presents unique challenges. Also, designing efficient and short time-consuming genome-editing tools with negligible off-target effects are in high demand for precision medicine. In the fourth annual Biopharmaceutical Research and Development Symposium (BRDS) held at the University of Nebraska Medical Center (UNMC) on September 7-8, 2017, we covered different facets of developing tools for precision medicine for therapeutic and diagnosis of genetic disorders.

Giving voice to varietyPre-Conference Workshop: 7 December 2017 Understanding the menopause: How to spot the signs and support your clients (and yourself) Nicki WilliamsPre-Conference Workshop: 7 December 2017 Resilience coaching: Beyond wellbeing Dr Carole PembertonCoaching in Higher Education Symposium Rebecca JonesConference Symposia and Keynotes: 8 December 2017 Doctoral Coaching Research Symposium Jonathan PassmoreKeynote address: Myles DowneyKeynote address: Tom SenskyKeynote address:

Giving voice to varietyPre-Conference Workshop: 7 December 2017 Understanding the menopause: How to spot the signs and support your clients (and yourself) Nicki WilliamsPre-Conference Workshop: 7 December 2017 Resilience coaching: Beyond wellbeing Dr Carole PembertonCoaching in Higher Education Symposium Rebecca JonesConference Symposia and Keynotes: 8 December 2017 Doctoral Coaching Research Symposium Jonathan PassmoreKeynote address: Myles DowneyKeynote address: Tom SenskyKeynote address:

Sleep medicine is coming of age in military medicine : Report from the Military Health System Research Symposium (2017) in Kissimmee, Florida.

In August 2017, the US Military Health System held its sixth annual Research Symposium for medical researchers from the US Army, Navy, Air Force, and Public Health Service. The symposium provides a collaborative environment for academia, industry, and military researchers who address advancement in areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, and Military Infectious Diseases. This year, Sleep Medicine received substantial attention with presentations scattered throughout the program, poster presentations as well as a scheduled breakout session with podium presentations. A brief description of the breakout session follows.

17th Annual AAVN Clinical Nutrition & Research Abstract Symposium

Journal of Animal Physiology and Animal NutritionVolume 101, Issue 6 p. 1067-1075 ABSTRACTS 17th Annual AAVN Clinical Nutrition & Research Abstract Symposium First published: 07 November 2017 https://doi.org/10.1111/jpn.12822Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume101, Issue6December 2017Pages 1067-1075 RelatedInformation

Participating in Research Symposia: Tales of Reinscription, Disruption, and Inclusivity

AbstractHaving participated in both the New Zealand Association for Environmental Education (NZAEE) and Australian Association for Environmental Education (AAEE) Research Symposia of 2016, the authors provide a critical analysis of the opportunities provided during these symposia for researchers to position themselves within the environmental education field. Each symposium is analysed in terms of its purpose and program structure, and the opportunities for researchers to communicate and share their ideas, build their research community, and frame their field. It was found that there were spaces for researchers to reinscribe the structures and practices of the environmental education field, but less space for its disruption. Furthermore, it seemed that there were some voices from the edge who were unintentionally silenced to some degree; for example, emerging researchers, women, and Indigenous people. It is recommended that symposia organisers and delegates give careful consideration to these spaces for disruption and to inclusivity when planning and attending future symposia.

Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.

The aim of this study was to summarize developments in novel therapeutics for ovarian cancer presented at the Ovarian Cancer Research Symposium held at the University of Washington. A symposium of the leaders in ovarian cancer research was convened to present and discuss current advances and future directions in ovarian cancer research. The fourth session was held on September 13, 2016, and focused on Novel Therapeutics for Ovarian Cancer. The session featured a keynote presentation on Novel Immunotherapeutics for Ovarian Cancer from Nora Disis and an invited oral presentation from Scott Kaufmann that discussed poly (ADP-ribose) polymerase (PARP) Inhibitor Combinations for the Treatment of Ovarian Cancer. Eight additional oral presentations were selected from abstract submissions. Thirty-eight abstracts were presented as posters highlighting recent advances in tumor immunology, PARP inhibition, chemoresistance, and novel targets for ovarian cancer therapy. PARP inhibitors, immunotherapies, and targeted therapies are but some of the expanding number of treatment options for ovarian cancer patients. Identification of the subsets of patients who will benefit most from these treatments remains the subject of intense preclinical and clinical research. Evidence presented at this symposium suggests that non-BRCA patients also benefit from PARP inhibitor therapies. Improved understanding of the mechanisms of chemoresistance and encouraging preclinical data presented for combinatorial approaches may soon yield new therapies for ovarian cancers that are resistant and refractory to standard treatments.

Tumor Microenvironment and Models of Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.

The aim of this study was to review the latest research advances on the topics of the ovarian cancer tumor microenvironment and models of ovarian cancer. In September 2016, a symposium of the leaders in the field of ovarian cancer research was convened to present and discuss current advances and future directions in ovarian cancer research. One session was dedicated to Tumor Microenvironment and Models of Ovarian Cancer, and included a keynote presentation from Anil Sood, MD, and an invited oral presentation from David Huntsman, MD. Eight additional oral presentations were selected from abstract submissions. Twenty-nine abstracts were presented in poster format and can be grouped into the categories of stromal cells in the microenvironment, immune cells in the microenvironment, epithelial-mesenchymal transition and metastasis, metabolomics, and model systems including spheroids, murine models, and other animal models. Rapid advances continue in our understanding of the influence of the tumor microenvironment on ovarian cancer progression and metastasis. Vascular endothelial cells, stromal cells, and immune cells all modulate epithelial tumor cell biology and therefore serve as potential targets for improved treatment responses either in conjunction with or instead of current treatment modalities. Characterization of the underlying genetic alterations in both the tumor cells and surrounding microenvironment cells enhances our understanding of tumor biology. Model systems including both in vitro and in vivo approaches allow novel advances. Technological advances including sequencing strategies, use of mass spectrometry for metabolomics and other studies, and bioengineering approaches all complement conventional methodologies to push forward our understanding and ultimately the treatment of ovarian cancer.

Meeting Report From the 2016 11th Biennial Ovarian Cancer Research Symposium: Mechanisms of Initiation and Progression of Ovarian Cancers.

The aim of this study was to review the latest research advances on the mechanisms of initiation and progression of ovarian cancer. At the 11th Biennial Ovarian Cancer Research Symposium, which was held in Seattle, Washington in September 2016, leaders in ovarian cancer research convened to present and discuss current advances and future directions in ovarian cancer research. One session was dedicated to Mechanisms of Initiation and Progression of Ovarian Cancer, and included a keynote presentation from Dr Ronny Drapkin, MD (University of Pennsylvania), and an invited oral presentation from Laising Yen, PhD (Baylor College of Medicine). Nine additional oral presentations were selected from abstract submissions. Thirty-three abstracts were presented in poster format and were grouped into the categories of mechanisms of the genesis of genomic instability, tumor initiation, metastases of ovarian cancers, innate and acquired chemotherapy resistance, tumor progression, tumor-initiating cell and chemotherapy resistance, and immunomodulation. Eradication of ovarian cancers requires clear understanding of molecular mechanisms of ovarian cancer initiation and progression. These mechanisms will not only drive the precision of early detection, but also discovery of new therapies to target precursor lesions and more advanced stage disease.

Research Summaries: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.

In September 2016, the 11th biennial ovarian cancer research symposium was presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. The 2016 symposium focused on 4 broad areas of research: Mechanisms of Initiation and Progression of Ovarian Cancer, Tumor Microenvironment and Models of Ovarian Cancer, Detection and Prevention of Ovarian Cancer, and Novel Therapeutics for Ovarian Cancer. The presentations and abstracts from each of these areas are reviewed in this supplement to the International Journal of Gynecologic Oncology.

Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.

The aim of this study is to provide a summary report on recent research advances in ovarian cancer prevention, screening, and early detection that were presented at the 11th Biennial Ovarian Cancer Research Symposium in Seattle, Wash. At the symposium, researchers from around the world participated in the poster, invited oral presentation and keynote presentation, and discussed the latest advances in the areas of cancer prevention, screening, and early detection. In the Scientific Session for Prevention, Screening, and Early Detection, Usha Menon, PhD (University of College London), presented exploratory studies from the ongoing UK Collaborative Trial of Ovarian Cancer Screening trial. Karen Lu, MD, presented her studies on BRCA testing and salpingectomies as prevention strategies. Eight speakers were selected from the abstracts for short oral presentations, and the topic ranges from Ovarian Cancer Early Detection Program by Saul Rivkin, MD, to the ultra-deep sequencing of somatic mutations in TP53 in normal and cancer patients by Rosana Risques, PhD. Fourteen additional poster presentations, ranging from the potential role of cancer stem cells in recurrence to retrotransposons in ovarian cancer development, round up the session. Although progress is being made in the areas of prevention, screening, and early detection, these advances have not yet translated into tangible clinical benefits for patients with ovarian cancer. A wide array of research topics presented in the session provides a glimmer of hope that better understanding of genetic risk factors, refining screening strategies, and developing new methods for early detection will eventually lead to improved outcome for patients with ovarian cancer.

Keynote speakers.

Asia-Pacific Journal of Clinical OncologyVolume 13, Issue S5 p. 6-6 KEYNOTE SPEAKERS Keynote speakers First published: 30 October 2017 https://doi.org/10.1111/ajco.12811Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume13, IssueS5Special Issue: 2017 Hunter Cancer Research Symposium, 24th November 2017, Hunter Medical Research Institute, Kookaburra Circuit, New Lambton Heights, NSW, AustraliaNovember 2017Pages 6-6 RelatedInformation

The 15th International Research Symposium on Service Excellence in Management (QUIS15)

The 15th International Research Symposium on Service Excellence in Management (QUIS15)

Research Symposium on Gentrification and Neighborhood Change

On May 25, 2016, the Federal Reserve Bank of Philadelphia, in partnership with HUD’s Office of Policy Development and Research, the NYU Furman Center and the Federal Reserve Bank of Minneapolis, hosted the Research Symposium on Gentrification and Neighborhood Change. This summary report highlights important research findings, policy implications, and examples of local efforts to promote equitable outcomes for gentrifying neighborhoods that were discussed at the symposium.

Introduction to the Research Symposium Forum.

The purpose of this introduction is to provide an overview of the articles contained within this research forum of JSLHR. Each of these articles is based upon presentations from the 2016 ASHA Research Symposium.

International perspectives on arts and dementia research

Review on the symposium for Arts and Dementia Research that took place between the 16 th and 20 th November 2016, at the Gerontological Society of America’s Annual Scientific Meeting.

Psychological factors surrounding disagreement in multicultural design team meetings

Our research contrasts two theories of creativity in multicultural teams. The dual-process model focuses on the degree of diversity, whereas cross-cultural psychology focuses on specific cultural compositions. In individualistic cultures, team members express more conflicts and benefit from it, compared to in collectivistic cultures that emphasise harmony. The relative representation of members from these cultures may affect team dynamics, conflict and creativity. We coded over 3100 speaker turns in the 11th Design Thinking Research Symposium data-set for the presence of disagreements and examined the effects of conflict phase and team diversity on creativity, promotion and prevention approaches using Linguistic Inquiry Word Count measures. We found that micro-conflicts increased insight words in the moment of the conflict. Individuals in more diverse team meetings of Scandinavians and South-East Asians expressed fewer conflicts than teams dominated by Scandinavians and were less likely to focus on potential gains when experiencing micro-conflicts. Regardless of conflict, the more culturally diverse teams were more likely to use insight and promotion words overall. There were no effects for prevention. These findings extend extant theory to different types of heterogeneous teams in a real-world design setting. This study is novel in combining theory on team cultural diversity with a micro-process method.

Supporting Undergraduate Research Symposia in the Sciences: Integrated Library Programming and Services

ABSTRACTLibraries are always looking for innovative ways to support the undergraduate research process. One way to provide this support is to offer an integrated suite of programs and services for undergraduate researchers in the sciences as they create and present research posters at a science symposium. The Dartmouth College Library developed a series of programs, including a symposium preparation session, library research award, and winner exhibit to increase support, expand outreach activities, and develop strong collaborations with students and other research support departments on campus. These programs help the library demonstrate value by supporting students as they disseminate their research.

5.0 Research Symposium: Social Neuroscience and Child and Adolescent Psychiatry Research Priorities at the National Institute of Mental Health

The goals of the 2017 research symposium are to highlight funding priorities of the NIMH relevant to the field of child and adolescent psychiatry and to present groundbreaking basic/translational research in the field of social neuroscience.